🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Severe Combined Immunodeficiency

The Experience of Screening for SCID NCT05651113n/a1 site📍 London King's College London · Tests: SCID Screening Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site📍 Pittsburgh Paul Szabolcs · Tests: data collection Targeting Real World Usage In Stroke Treatment NCT07474935n/a13 sites📍 Brest📍 Paris📍 Erfurt Phenox GmbH · Tests: Aneurysm Treatment with a Neurovascular Flow Diverter, Dissection Treatment with a Neurovascular Flow Diverter, Perfora… Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning NCT03311503Phase 1, Phase 24 sites📍 Los Angeles📍 Atlanta📍 Boston David Williams · Tests: autologous CD34+ cell transduced with G2SCID vector Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) NCT01306019Phase 1, Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Ex vivo culture and transduction of the patient's autologous CD34+ HSC with lentivirus vector VSV-G pseudotyped CL… Evaluation of Patients With Immune Function Abnormalities NCT00128973n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD) NCT07284641Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: Hematopoietic stem cell transplant (HSCT) Autologous Gene Therapy for Artemis-Deficient SCID NCT03538899Phase 1, Phase 21 site📍 San Francisco University of California, San Francisco · Tests: AProArt-CD34, CliniMACS® CD34 Reagent System cell sorter device, Busulfan Genetic Basis of Immunodeficiency NCT00055172n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa Safety and Efficacy Study of Transplantation of Autologous CD34+ Cells Transduced With the G2ARTE Lentiviral Vector Expressing the DCLRE1C cDNA in Artemis (DCLRE1C) Deficient Severe Combined Immunodeficiency Patients (ARTEGENE) NCT05071222Phase 1, Phase 21 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: ARTEGENE drug product
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy